(Q43116303)

English

Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients

scientific article published on 26 March 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

author name string

Alexander Diehl

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Lisa Ulmer

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Jochen Mutschler

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Hans Herre

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Bertram Krumm

5

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Bernhard Croissant

6

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Karl Mann

7

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Falk Kiefer

8

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

26 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Alcohol and Alcoholism

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

271-277

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

Treatment of alcoholic violent offenders: ethics and efficacy

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

Safety issues concerning the use of disulfiram in treating alcohol dependence

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

Disulfiram: cautions on liver function; how to supervise

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

Does acamprosate improve reduction of drinking as well as aiding abstinence?

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

Alcoholism in women: is it different in onset and outcome compared to men?

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

Does disulfiram have a role in alcoholism treatment today?

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

Follow-up of 180 Alcoholic Patients for up to 7 Years After Outpatient Treatment: Impact of Alcohol Deterrents on Outcome

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

Pharmacotherapy of alcohol dependence: a review of the clinical data

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

Neuroimaging of gender differences in alcohol dependence: are women more vulnerable?

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

Physicians’ opinions about medications to treat alcoholism

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

Naltrexone and disulfiram in patients with alcohol dependence and current depression.

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGQ017

21 January 2018

Identifiers

10.1093/ALCALC/AGQ017

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43116303&oldid=1981209346"